Hemairologic Malignancy Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma

Cancer research · Diffuse large B-cell lymphoma

Detectable ctDNA after two cycles and after therapy was highly prognostic.

Evidence level: Sejtvonalas. Laboratóriumi sejtekben vizsgálták.

Original source

Related signals

• Diffuse Large B‑Cell Lymphoma – Global Clinical Trial Landscape (2024)
• Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
• Mantle‑Cell Lymphoma (MCL)
• Inhibition of autoantigen‑induced B‑cell receptor (BCR) internalization as a therapeutic strategy in diffuse large B cell lymphoma (DLBCL)
• Successful treatment of primary refractory DLBCL/HGBL - MYC/BCL2 transformed from FL using glofitamab: a case report